FDA Investigator Habacuc V Barrera
Habacuc V Barrera has inspections in 5 countries as of 15 Mar 2024. Habacuc V Barrera has collaborated with a combined 2873 experts on various inspections, contributing to compliance and improvement across diverse sectors.
Investigator Details
Number of Inspected Sites:
79
Last Inspection Date:
15 Mar 2024
Investigator Role:
FDA Investigator
Redica ID:
Country:
United States of America,
India,
Serbia,
Spain,
Taiwan
Co-Investigator(s):
Adam C Hipko,
Adrian Rodriguez,
Albert F Peacock, PhD,
Albert Peacock, PhD,
Alcee M Tavarez,
Allen F Hall,
Alvaro G Dominguez,
Andrea A Branche,
Angela Shepas,
Anh M Lac,
Anya D Lockett Evans,
Arie R Dyk,
Ashley N Williams,
Audrey J Yarbrough,
Benjamin K Kingsley,
Bernardino E Mendez,
Brackens Harris,
Brian J Ryan,
Camerson E Moore,
Carol A Declouette Wilburn,
Catherine A Spratte,
Chad J Whitwell,
Charles B Steinmiller,
Charles D Brown,
Chmura,
Christopher D Rush,
Christopher J Hurst,
Christopher J Smith,
Christopher L Jacobs,
Christopher T Peters,
Cody J Alley,
Connie Hannon Rabel,
Connie L Hannon Rabel,
Connie Lucero,
Constance M Dobbins,
Courtney N Long,
Cymbre Weatherly,
Cynthia A Harris, MD, RN,
Daniel J Lahar,
Daniell Gill, Jr,
Danielle Lyke,
Daphne A Videau,
Darla J Christopher,
David M Beltran,
Dawn P Hall,
Debra D Devlieger,
Debra Devlieger,
Denise Connelly,
Deniza Karacic,
Ed Gonzalez Vazquez,
Edwin Ramos,
Elizabeth D Connell,
Elizabeth P Mayer,
Elkins,
Eric R Heebner,
Erica Uribe,
Ernest Serna, III,
Fernando C Martinez,
Florecia S Philogene,
Francisco J Mendoza,
Franklin R Harris,
Frans E Mercado,
Gery M Duparc,
Glasgow,
Grant,
H Ljamilla Selby,
Habacus V Barrera,
Hala L Selby,
Huanli Liu,
Hung V Le,
Iris C Macinnes,
Jacob S Foster,
Jacob W Reynolds,
Jamie M Bumpas,
Janete F Guardia,
Jasmine Y Wang,
Jeffrey R Wooley,
Jennifer Hua,
Jennifer Owens Dowdy,
Jeremi S Mullins,
Jeremy W Rotton,
Jerry E Lott,
Joanne M Schlossin,
Jocelyn C Turner,
Joel D Martinez,
Johann M Fitch,
Johnson,
Jonathan A Womack,
Joy L Ramsey,
Juan D Lopez,
Kamara Tx,
Karen C Daugherty,
Kari M Johansen,
Kari M Lanynor,
Kelly D Sheppard,
Kelvin R Wright,
Kristi B Panzer,
Leighton K Ngai,
Lillie M Johnson,
Lillie M Young,
Lisa A Doyle,
Lisa M Puttonen,
Lorie S Hannappel,
Luis A Salinas,
Maotang Zhou, PhD,
Marc R Dickens,
Margaret M Annes,
Mark A Guerra,
Mark C Flotte,
Marlena C Freeman,
Martinez,
Mary A Millner,
Mary Anne K Joseph,
Massoud Motamed,
Matthew R Maddox,
Matthew S Mccollough,
Merelynn Rhoten,
Michael L Jones,
Monique Rac Lester,
Natasha N Livingston,
Natasha N Mccants,
Patricia M Jacobs,
Patrick D Stone, MS,
Patty P Kaewussdangkul,
Paul E Frazier,
Pauline N Logan,
Percal Perez,
Perla M Castillo,
Philip M Steele, PhD,
Phillip D Waldron,
Phillip J Sample,
Priya J Rathnam,
Rafael H Ortiz,
Ralph H Vocque,
Rebecca Rodriguez,
Rene R Ramirez,
Rhonda L Dash,
Robert M Tillman,
Robert T Lorenz,
Rodriguez,
Ronan F King,
Ruth E Medcalf,
Saijal P Naik,
Sha'tina R Alridge,
Shawn E Larson,
Sherrie L Krolczyk,
Sonia R Peterson,
Staci G Mcallister,
State Agency,
Stephen D Brown,
Stephen L Beekman,
Steven L Strom,
Susan C Baltzer,
Tawny L Colling,
Theresa Kirkham (NMI),
Thomas B Smith,
Thomas J Arista,
Toby Vern H Hill,
Torrance J Slayton,
Tracy J Washington,
Travis M Beard,
Tricia S Martinez,
Vivian Garcia,
Young M Yoon,
Yvette S Montes,
Zerita White
Habacuc V Barrera's Documents
Publish Date | Document Type | Title |
---|---|---|
June, 2023 | FDA 483 | Ravi Ganeshappa, M.D. - Form 483, 2023-06-30 |
August, 2022 | FDA 483 | Murtaza Mussaji, D.O.. - Form 483, 2022-08-16 |
December, 2022 | FDA 483 | Darrell T. Herrington, DO - Form 483, 2022-12-16 |
February, 2013 | FDA 483 | Nexgen Pharma, Inc. - Form 483, 2013-02-05 |
September, 2019 | FDA 483 | Turner Medical Inc - Form 483, 2019-09-12 |
December, 2021 | FDA 483 | Koriand'r Williams, M.D. - Form 483, 2022-01-31 |
December, 2021 | EIR | Koriand'r Williams, M.D. - EIR, 2021-12-22 |
February, 2013 | EIR | Nexgen Pharma, Inc. - EIR, 2013-02-05 |
May, 2015 | FDA 483 | Blue Bell Creameries, L.P. - Form 483, 2015-05-01 |
May, 2015 | FDA 483 Response | Blue Bell Creameries, L.P. - Form 483R, 2015-05-22 |
January, 2023 | FDA 483 | Sloan W. Rush, M.D. - Form 483, 2023-01-26 |
November, 2023 | FDA 483 | Carl P. Griffin, M.D. - Form 483, 2023-11-17 |
February, 2024 | FDA 483 | Patrick Odia, MD - Form 483, 2024-02-16 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](https://redica.com/document-store/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more